விசை தொடங்குகிறது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விசை தொடங்குகிறது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விசை தொடங்குகிறது Today - Breaking & Trending Today

Advantage MSMEs - The Hindu BusinessLine

Advantage MSMEs - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Atmanirbhar Bharat , Department Of Pharmaceuticals , Indian Economic , Dhruva Advisors , Union Budget , Atmanirbhar Bharat , Finance Minister , Production Linked Incentive , Indian Economic Survey , Active Pharmaceutical , Key Starting , Drug Intermediates , Global Manufacturing Revenue , துறை ஆஃப் மருந்துகள் , இந்தியன் பொருளாதார , தொழிற்சங்கம் பட்ஜெட் , நிதி அமைச்சர் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , இந்தியன் பொருளாதார கணக்கெடுப்பு , செயலில் மருந்து , விசை தொடங்குகிறது , மருந்து இடைத்தரகர்கள் , உலகளாவிய உற்பத்தி வருவாய் ,

Budget 2021 Could Be The Vaccine For The Pharmaceutical Industry

Budget 2021 could be the vaccine for the pharmaceutical industry
Given the government’s ambition to make India a $5 trillion economy in the next five years, pharmaceutical and life science could be the ‘target sector’ in Budget 2021
Hitesh Sharma
Representative Image
The pharmaceutical and life science sector has played a pivotal role during this ongoing pandemic which has shook the world economy, India being no different. Being an essential sector, it actually rose to the occasion first in identifying and supplying medicines to control the breakout. Thereafter, the innovators combined with global support are now providing India the vaccines to bring back the economy. ....

Aarogya Sethu , Key Starting , Drug Intermediaries , Active Pharmaceutical Ingredients , Hitesh Sharma , Tax Partner , Life Science Sector Leader , Co Vid , Budget 2021 , Union Budget , Nirmala Sitharaman , ஆரோக்கிய செத்து , விசை தொடங்குகிறது , மருந்து இடைத்தரகர்கள் , செயலில் மருந்து பொருட்கள் , ஹிடேஷ் ஷர்மா , வரி கூட்டாளர் , வாழ்க்கை அறிவியல் துறை தலைவர் , இணை வித் , தொழிற்சங்கம் பட்ஜெட் ,

Pharma revenue, margins likely to remain healthy in next fiscal: ICRA

With inelastic demand for drugs and resumption of production to the near pre-Covid levels by Q3 FY2021, revenue growth for IPM (Indian Pharmaceutical Market) is expected to be 7-9 per cent in FY2021 despite muted growth in Q1 FY2021, ratings agency ICRA said in a report.
The revenue growth in FY2022 is expected to be slightly better at 8-11 per cent, though lower incidences of acute diseases, lesser OPDs and elective surgeries may continue to have some bearing on growth and will depend upon the course of the pandemic, the report added.
The API/KSM (Key Starting mAterials) supplies from China, which were initially hit due to the Covid-19, have resumed gradually since March 2020 and are nearing the normalcy levels. Approximately 60 per cent of the APIs/KSM consumed, is imported from China. ....

Indian Pharmaceutical Market , Key Starting , இந்தியன் மருந்து சந்தை , விசை தொடங்குகிறது ,

Pharma sector revenue, margins likely to remain healthy in FY2022: ICRA

Pharma sector revenue, margins likely to remain healthy in FY2022: ICRA
By
IANS
|
Published on
Wed, Dec 23 2020 15:27 IST
|
0 Views
ICRA. (Photo: ICRA). Image Source: IANS News
New Delhi, Dec 23 : With inelastic demand for drugs and resumption of production to the near pre-Covid levels by Q3 FY2021, revenue growth for IPM (Indian Pharmaceutical Market) is expected to be 7-9 per cent in FY2021 despite muted growth in Q1 FY2021, ratings agency ICRA said in a report.
The revenue growth in FY2022 is expected to be slightly better at 8-11 per cent, though lower incidences of acute diseases, lesser OPDs and elective surgeries may continue to have some bearing on growth and will depend upon the course of the pandemic, the report added. ....

New Delhi , Indian Pharmaceutical Market , Key Starting , புதியது டெல்ஹி , இந்தியன் மருந்து சந்தை , விசை தொடங்குகிறது ,